WBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes Transaction
Posted: Jun 25th, 2014In: Press ReleasesWBB Securities acted as co-manager on a convertible senior notes transaction for TetraLogic Pharmaceuticals, Inc.
Read More about WBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes TransactionMedtronic, Covidien, And The Health Of The U.S. Tax Code
Posted: Jun 17th, 2014In: Opinions & FeaturesOn June 15, Medtronic, Inc. announced its proposed acquisition of Covidien plc for $42.9 billion in cash and stock.
Read More about Medtronic, Covidien, And The Health Of The U.S. Tax CodeWBB Securities Acts as Exclusive Placement Agent to Cytori Therapeutics
Posted: Jun 6th, 2014In: Press ReleasesWBB Securities acted as exclusive placement agent on a registered direct financing for Cytori Therapeutics, a clinical phase regenerative medicine company.
Read More about WBB Securities Acts as Exclusive Placement Agent to Cytori Therapeutics